Frontlight ResearchEarly access
TerminatedNo phase
ACT for HIV-Positive Men
Key facts
- Who runs it
- University of Alabama at Birmingham
- Where
- Birmingham, United StatesSee the site
- Trial code
- Status
- Terminated
- People taking part
- 1 person enrolled
- Started
- 15 Jan 2025
- Ended
- 16 Apr 2026
- Type of study
- Interventional
- Treatments tested
- Acceptance and commitment therapy
- Record updated
- 20 April 2026
- Why it stopped
- Insufficient administrative resources.
Who can take part
- Age
- 18 years and older
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- identify as a man
- be at least 18 years old
- has been diagnosed with HIV by a healthcare professional
Who cannot take part
- is currently diagnosed with any eating disorder
- has engaged in self-harm within the last three months
- has attempted suicide within the last year
- has had an active plan to attempt suicide within the last 30 days
- has experienced hallucinations or delusions within the last 30 days
- has used narcotics within the last 7 days (heroin, meth, crack cocaine, opioids)
Where in United States
- University of Alabama at BirminghamBirmingham, United States
About the trial
What the trial wants to find out
The purpose of the current study is to examine the feasibility and effectiveness of acceptance and commitment therapy, a specific form of cognitive-behavioral therapy, for treating general mental health concerns among HIV-positive men.
The group in the trial
- Acceptance and commitment therapyTreatment being tested
Trial of acceptance and commitment therapy for hiv-positive men.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of the Effectiveness of Acceptance and Commitment Therapy for General Mental Health Concerns in HIV-Positive Men
- Record updated
- 20 April 2026